Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2931
Selected: 0
NCT IDTitle
NCT07285798A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
NCT05651932A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
NCT03619876Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
NCT04941755A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
NCT00077233FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
NCT00550615Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT04879368RegoNivo vs Standard of Care Chemotherapy in AGOC
NCT02285985Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
NCT00037089A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
NCT02041533An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
NCT06133049A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
NCT00904176Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
NCT04465643Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
NCT00594984Phase I/II Combination With Irinotecan- Erbitux
NCT02007655Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
NCT01766817Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
NCT03121417Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer
NCT00094991Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes
NCT00482703A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
NCT03425461Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
NCT00546780A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse
NCT03663946A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread
NCT04206488A Study of JNJ-70033093 and Digoxin in Healthy Participants
NCT02546791Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study
NCT03349710Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer
NCT03001882An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
NCT00112580MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
NCT06295159Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
NCT00002360A Study Comparing Two Forms of Didanosine in HIV-infected Patients
NCT03881059Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
NCT00035789A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen
NCT05547490A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis
NCT00729950Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
NCT04787991Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
NCT04464759A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
NCT00002420The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT01195727Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
NCT00423891A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
NCT00644488A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer
NCT01279954Abatacept in the Treatment of Uveitis
NCT02213068Belatacept 3 Month Post Transplant Conversion Study
NCT01763190Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment
NCT02564497A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C
NCT01137474A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
NCT06408259Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
NCT01535677To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately
NCT00656734Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.
NCT02572167A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma
NCT03416244A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer
NCT01681212Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma